Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options

Clin Infect Dis. 2011 Mar 1;52(5):690-1. doi: 10.1093/cid/ciq194. Epub 2011 Jan 10.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Typing Techniques
  • Drug Resistance, Multiple, Bacterial*
  • Escherichia coli / classification
  • Escherichia coli / drug effects
  • Escherichia coli / enzymology*
  • Escherichia coli / isolation & purification*
  • Escherichia coli Infections / microbiology*
  • Genotype
  • Humans
  • Microbial Sensitivity Tests
  • Molecular Typing
  • beta-Lactamases / biosynthesis*

Substances

  • Anti-Bacterial Agents
  • beta-Lactamases